INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 29 February 2012
Total net assets |
£114.7m |
NAV per share |
206.8p |
Share price |
183.0p |
Total value of unquoted investments |
£18.2m |
Total number of portfolio companies |
67 |
Cash |
8% NAV |
Cash committed and reserved to unquoted investments |
(8)% NAV |
Portfolio companies with < 1 year of cash |
9.4% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
4.4 |
Celgene |
4.2 |
Teva |
4.0 |
Insulet |
3.8 |
Alexion |
3.5 |
Pharmaxis Biogen Shire |
3.4 3.1 2.8 |
Gilead Aptiv Solutions |
2.8 2.8 |
|
----------- |
Total |
34.8 |
Geographical Allocation |
% |
United States & Canada |
70 |
Europe |
15 |
Israel |
4 |
Australia |
3 |
Cash |
8 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
76 |
Unquoted |
16 |
Cash |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 MARCH 2012